Literature DB >> 20639684

Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.

Matthias R Meyer1, Oliver Baretella, Eric R Prossnitz, Matthias Barton.   

Abstract

Endogenous estrogens protect from coronary artery disease in premenopausal women, but the mechanisms involved are only partly understood. This study investigated whether activation of the novel G protein-coupled estrogen receptor (GPER, formerly known as GPR30) affects coronary artery tone, and whether this is affected by concomitant blockade of estrogen receptors (ER) alpha and beta. Rings of epicardial porcine coronary arteries suspended in organ chambers were precontracted with prostaglandin F(2)alpha, and direct effects of G-1 (GPER agonist) and ICI 182,780 (GPER agonist and ERalpha/ERbeta antagonist) were determined. In addition, indirect effects on contractility to endothelin-1 and serotonin (a vasoconstrictor released from aggregating platelets during acute myocardial infarction) were assessed. ICI 182,780 and G-1 caused acute dilation of coronary arteries to a comparable degree (p < 0.05 vs. solvent control). Both GPER agonists attenuated contractions to endothelin-1 (p < 0.05 vs. ethanol), but not to serotonin (n.s.). In summary, these findings provide evidence for direct and indirect coronary artery dilator effects of GPER independent of ERalpha and ERbeta, and are the first demonstration of arterial vasodilation in response to ICI 182,780. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639684      PMCID: PMC3201835          DOI: 10.1159/000315497

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  44 in total

1.  A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat.

Authors:  E Filice; A G Recchia; D Pellegrino; T Angelone; M Maggiolini; M C Cerra
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

2.  A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.

Authors:  Jean Chrisostome Bopassa; Mansoureh Eghbali; Ligia Toro; Enrico Stefani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-30       Impact factor: 4.733

3.  Lasofoxifene in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Kristine Ensrud; Pierre D Delmas; Andrea Z LaCroix; Slobodan Vukicevic; David M Reid; Steven Goldstein; Usha Sriram; Andy Lee; John Thompson; Roisin A Armstrong; David D Thompson; Trevor Powles; Jose Zanchetta; David Kendler; Patrick Neven; Richard Eastell
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

4.  Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity.

Authors:  Elvira Haas; Indranil Bhattacharya; Eugen Brailoiu; Marlen Damjanović; G Cristina Brailoiu; Xin Gao; Laurence Mueller-Guerre; Nicole A Marjon; André Gut; Roberta Minotti; Matthias R Meyer; Kerstin Amann; Emerita Ammann; Ana Perez-Dominguez; Michele Genoni; Deborah J Clegg; Nae J Dun; Thomas C Resta; Eric R Prossnitz; Matthias Barton
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

5.  Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries.

Authors:  Tobias Traupe; Christoph D Stettler; Huige Li; Elvira Haas; Indranil Bhattacharya; Roberta Minotti; Matthias Barton
Journal:  Hypertension       Date:  2007-04-30       Impact factor: 10.190

6.  Vasorelaxant action of 17 -estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors.

Authors:  Pierre-André Scott; André Tremblay; Michèle Brochu; Jean St-Louis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-19       Impact factor: 4.733

7.  Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.

Authors:  Anne M Deschamps; Elizabeth Murphy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

8.  Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.

Authors:  Sarah Hoffmann Lindsey; Jonathan A Cohen; K Bridget Brosnihan; Patricia E Gallagher; Mark C Chappell
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

9.  Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.

Authors:  Peter Collins; Lori Mosca; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Messan G Amewou-Atisso; Mark B Effron; Sherie A Dowsett; Elizabeth Barrett-Connor; Nanette K Wenger
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

10.  Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries.

Authors:  Brad R S Broughton; Alyson A Miller; Christopher G Sobey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

View more
  59 in total

1.  Oestrogen upregulates the sarcoplasmic reticulum Ca(2+) ATPase pump in coronary arteries.

Authors:  Brent J F Hill; Edwin Muldrew
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-06       Impact factor: 2.557

Review 2.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

3.  Role of GPER in estrogen-dependent nitric oxide formation and vasodilation.

Authors:  Natalie C Fredette; Matthias R Meyer; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-05-18       Impact factor: 4.292

4.  A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.

Authors:  Chetana M Revankar; Cristian G Bologa; Richard A Pepermans; Geetanjali Sharma; Whitney K Petrie; Sara N Alcon; Angela S Field; Chinnasamy Ramesh; Matthew A Parker; Nikolay P Savchuk; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz
Journal:  Cell Chem Biol       Date:  2019-11-06       Impact factor: 8.116

Review 5.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

Review 6.  Influence of sex on cardiovascular drug responses: role of estrogen.

Authors:  Abdel A Abdel-Rahman
Journal:  Curr Opin Pharmacol       Date:  2017-03-21       Impact factor: 5.547

Review 7.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

Authors:  Austin C Boese; Seong C Kim; Ke-Jie Yin; Jean-Pyo Lee; Milton H Hamblin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

8.  Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction.

Authors:  Matthias R Meyer; Kerstin Amann; Angela S Field; Chelin Hu; Helen J Hathaway; Nancy L Kanagy; Mary K Walker; Matthias Barton; Eric R Prossnitz
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

9.  GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011

Review 10.  G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis.

Authors:  Haifei Shi; Shiva Priya Dharshan Senthil Kumar; Xian Liu
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.